Dietary polyphenols in cancer prevention: The example of the flavonoid quercetin in leukemia

Annals of the New York Academy of Sciences

Volumn 1259, Issue 1, 2012, Pages 95-103

  Spagnuolo, Carmela ^a   Russo, Maria ^a   Bilotto, Stefania ^a   Tedesco, Idolo ^a   Laratta, Bruna ^b   Russo, Gian Luigi ^a  

^a CNR   (Italy)

^b CNR   (Italy)

Author keywords

Apoptosis; Chemoprevention; Chronic lymphocytic leukemia; Phytochemicals; Quercetin

Indexed keywords

ANTINEOPLASTIC AGENT; FAS ANTIGEN; FLUDARABINE; MESSENGER RNA; POLYPHENOL; PROTEIN BCL 2; PROTEIN MCL 1; QUERCETIN; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADJUVANT THERAPY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER PREVENTION; CHRONIC LYMPHATIC LEUKEMIA; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG UPTAKE; HUMAN; LEUKEMIA CELL LINE; NEPHROTOXICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA STABILITY;

EID: 84863514720     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06599.x     Document Type: Article

References (61)

1. Riboli, E. & T. Norat 2003. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 78: 559S-569S.
2. Surh, Y.J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3: 768-780.
3. D'Incalci, M., W.P. Steward & A.J. Gescher 2005. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol. 6: 899-904.
4. Aune, D. et al 2011. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 141: 106-118.
5. Boffetta, P. et al 2010. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 102: 529-537.
6. Crowe, F.L. et al 2011. Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur. Heart J. 32: 1235-1243.
7. Dauchet, L. et al 2006. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J. Nutr. 136: 2588-2593.
8. McCullough, M.L. et al 2011. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol. Biomarkers Prev. 20: 1089-1097.
9. Van Duyn, M.A. & E. Pivonka 2000. Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature. J. Am. Diet Assoc. 100: 1511-1521.
10. Sporn, M.B. & N. Suh 2002. Chemoprevention: an essential approach to controlling cancer. Nat. Rev. Cancer 2: 537-543.
11. Kelloff, G.J. et al 2006. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward. Clin. Cancer Res. 12: 3661-3697.
12. Russo, M. et al 2005. Dietary phytochemicals in chemoprevention of cancer. Curr. Med. Chem. Immunol. Endocr. Metabol. Agents 5: 61-72.
13. Johnson, I.T. 2007. Phytochemicals and cancer. Proc. Nutr. Soc. 66: 207-215.
14. Russo, M. et al 2012. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83: 6-15.
15. Hanahan, D. & R.A. Weinberg 2000. The hallmarks of cancer. Cell 100: 57-70.
16. Hanahan, D. & R.A. Weinberg 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
17. Boots, A.W., G.R. Haenen & A. Bast 2008. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 585: 325-337.
18. Mertens-Talcott, S.U., S.T. Talcott & S.S. Percival 2003. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J. Nutr. 133: 2669-2674.
19. Mertens-Talcott, S.U. et al 2005. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J. Nutr. 135: 609-614.
20. Wang, P., D. Heber & S.M. Henning 2012. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct. Mar 22. [Epub ahead of print].
21. Mouria, M. et al 2002. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 98: 761-769.
22. Mertens-Talcott, S.U. & S.S. Percival 2005. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 218: 141-151.
23. Ferrer, P. et al 2005. Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia 7: 37-47.
24. Mikstacka, R., A.M. Rimando & E. Ignatowicz 2010. Antioxidant effect of trans-resveratrol, pterostilbene, quercetin and their combinations in human erythrocytes in vitro. Plant Foods Hum. Nutr. 65: 57-63.
25. Russo, M. et al 1999. Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett. 462: 322-328.
26. Russo, M. et al 2003. Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Calpha. Oncogene 22: 3330-3342.
27. Russo, M. et al 2010. Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. Br. J. Cancer 103: 642-648.
28. Harwood, M. et al 2007. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 45: 2179-2205.
29. Conquer, J.A. et al 1998. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 128: 593-597.
30. Manach, C. et al 2005. Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81: 230S-242S.
31. Scalbert, A. et al 2011. Databases on food phytochemicals and their health-promoting effects. J. Agric. Food Chem. 59: 4331-4348.
32. Tedesco, I., M. Russo & G.L. Russo 2010. Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance'. Hum. Exp. Toxicol. 29: 1029-1031.
33. IARC. 1999. Quercetin. IARC monographs on the evaluation of carcinogenic risks to human, Vol. 73: 497-515.
34. Vanhees, K. et al 2011. Prenatal exposure to flavonoids: implication for cancer risk. Toxicol. Sci. 120: 59-67.
35. Vanhees, K. et al 2012. Maternal intake of quercetin during gestation alters ex vivo benzo[a]pyrene metabolism and DNA adduct formation in adult offspring. Mutagenesis. First published online: February 14, 2012.
36. Vanhees, K. et al 2011. Maternal quercetin intake during pregnancy results in an adapted iron homeostasis at adulthood. Toxicology 290: 350-358.
37. Utesch, D. et al 2008. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat. Res. 654: 38-44.
38. Ferry, D.R. et al 1996. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2: 659-668.
39. Russo, M. et al 2010. Exploring death receptor pathways as selective targets in cancer therapy. Biochem. Pharmacol. 80: 674-682.
40. Taylor, R.C., S.P. Cullen & S.J. Martin 2008. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9: 231-241.
41. Russo, G.L. 2007. Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 74: 533-544.
42. Larocca, L.M. et al 1997. Differential sensitivity of leukemic and normal hematopoietic progenitors to the killing effect of hyperthermia and quercetin used in combination: role of heat-shock protein-70. Int. J. Cancer 73: 75-83.
43. Larocca, L.M. et al 1996. Quercetin and the growth of leukemic progenitors. Leuk. Lymphoma. 23: 49-53.
44. Larocca, L.M. et al 1995. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood 85: 3654-3661.
45. Avci, C.B. et al 2011. Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells. Hematology 16: 303-307.
46. Lee, W.J., Y.R. Chen & T.H. Tseng 2011. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol. Rep. 25: 583-591.
47. Kawahara, T. et al 2009. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 29: 4629-4632.
48. Yu, C.S. et al 2010. Quercetin inhibited murine leukemia WEHI-3 cells in vivo and promoted immune response. Phytother. Res. 24: 163-168.
49. Yee, K.W. & S.M. O'Brien 2006. Chronic lymphocytic leukemia: diagnosis and treatment. Mayo Clin. Proc. 81: 1105-1129.
50. MacFarlane, M. et al 2002. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 21: 6809-6818.
51. MacFarlane, M. et al 2005. Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell Death Differ. 12: 773-782.
52. Schnaiter, A. & S. Stilgenbauer 2010. Refractory chronic lymphocytic leukemia-new therapeutic strategies. Oncotarget 1: 472-482.
53. Binet, J.L. 1993. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL. Nouv. Rev. Fr. Hematol. 35: 5-7.
54. Packham, G. & F.K. Stevenson 2005. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology 114: 441-449.
55. Pepper, C. et al 2008. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 112: 3807-3817.
56. Spagnuolo, C. et al 2011. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. Br. J. Cancer 105: 221-230.
57. Yuan, B.Z., J. Chapman & S.H. Reynolds 2009. Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage. Oncogene 28: 3775-3786.
58. Weng, C. et al 2005. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J. Biol. Chem. 280: 10491-10500.
59. Lamson, D.W. & M.S. Brignall 2000. Antioxidants and cancer, part 3: quercetin. Altern. Med. Rev. 5: 196-208.
60. Scalbert, A. & G. Williamson 2000. Dietary intake and bioavailability of polyphenols. J. Nutr. 130: 2073S-2085S.
61. Scaffidi, C. et al 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687.